Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS)

PCT, a subsidiary of Caladrius Biosciences, is a leading development and manufacturing partner to the cell therapy industry. PCT works with its clients to overcome the fundamental challenges of cell therapy manufacturing by providing a wide range of innovative services including product and process development, GMP manufacturing, engineering and automation, cell and tissue processing, logistics, storage and distribution, as well as expert consulting and regulatory support. PCT and Hitachi Chemical Co. have entered into a strategic global collaboration to accelerate the creation of a global commercial cell therapy development and manufacturing enterprise with deep engineering expertise. *

	Start	2017-05-01 renamed
	End	2020-09-23 renamed
	Group	Resonac (Group)
	Today	Minaris Regenerative Medicine, LLC
	Predecessor	PCT LLC (US, Hitachi, formerly sub of Caladrius Biosciences)
	Successor	Minaris Regenerative Medicine, LLC
	Industry	cell therapy
	Industry 2	contract manufacturing (biologicals)
	Person	Preti, Robert A. (Hitachi 201901 CEO Hitachi Chemical Advanced Therapeutics Solutions + General Manager RegMed business)

	City	n. a.
		Address record changed: 2019-02-01

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-06-07